VANECK BIOTECH ETF (BBH) Stock Price, Forecast & Analysis
USA - NASDAQ:BBH - US92189F7261 - ETF
178.67 USD
-1.36 (-0.76%)
We assign a fundamental rating of 4 out of 10 to BBH. BBH was compared to 82 industry peers in the Automobile Components industry. BBH has only an average score on both its financial health and profitability. BBH is valied quite expensively at the moment, while it does show a decent growth rate. BBH also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
In the past year BBH was profitable.
In the past year BBH had a positive cash flow from operations.
In the past 5 years BBH has always been profitable.
In the past 5 years BBH always reported a positive cash flow from operatings.
1.2 Ratios
BBH has a Return On Assets (4.39%) which is comparable to the rest of the industry.
BBH has a Return On Equity of 8.81%. This is comparable to the rest of the industry: BBH outperforms 46.34% of its industry peers.
Looking at the Return On Invested Capital, with a value of 8.17%, BBH is in line with its industry, outperforming 42.68% of the companies in the same industry.
BBH had an Average Return On Invested Capital over the past 3 years of 9.25%. This is in line with the industry average of 8.52%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.39% | ||
| ROE | 8.81% | ||
| ROIC | 8.17% |
ROA(3y)5.45%
ROA(5y)4.73%
ROE(3y)10.95%
ROE(5y)10.02%
ROIC(3y)9.25%
ROIC(5y)8.5%
1.3 Margins
BBH has a Profit Margin (5.84%) which is in line with its industry peers.
BBH's Profit Margin has been stable in the last couple of years.
The Operating Margin of BBH (10.65%) is comparable to the rest of the industry.
BBH's Operating Margin has been stable in the last couple of years.
BBH has a Gross Margin (27.60%) which is in line with its industry peers.
BBH's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.65% | ||
| PM (TTM) | 5.84% | ||
| GM | 27.6% |
OM growth 3Y-2.46%
OM growth 5Y-1.24%
PM growth 3Y-3.58%
PM growth 5Y-0.79%
GM growth 3Y-0.99%
GM growth 5Y-0.59%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BBH is still creating some value.
BBH has less shares outstanding than it did 1 year ago.
BBH has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, BBH has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 5.59 indicates that BBH is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 5.59, BBH belongs to the best of the industry, outperforming 87.80% of the companies in the same industry.
The Debt to FCF ratio of BBH is 6.05, which is on the high side as it means it would take BBH, 6.05 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 6.05, BBH is not doing good in the industry: 63.41% of the companies in the same industry are doing better.
BBH has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
BBH has a worse Debt to Equity ratio (0.32) than 63.41% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.32 | ||
| Debt/FCF | 6.05 | ||
| Altman-Z | 5.59 |
ROIC/WACC1.04
WACC7.88%
2.3 Liquidity
BBH has a Current Ratio of 1.80. This is a normal value and indicates that BBH is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of BBH (1.80) is worse than 71.95% of its industry peers.
A Quick Ratio of 1.12 indicates that BBH should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.12, BBH is doing worse than 74.39% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.8 | ||
| Quick Ratio | 1.12 |
3. Growth
3.1 Past
The earnings per share for BBH have decreased strongly by -18.28% in the last year.
BBH shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.64% yearly.
Looking at the last year, BBH shows a decrease in Revenue. The Revenue has decreased by -3.62% in the last year.
The Revenue has been growing slightly by 2.41% on average over the past years.
EPS 1Y (TTM)-18.28%
EPS 3Y0.78%
EPS 5Y1.64%
EPS Q2Q%-26.88%
Revenue 1Y (TTM)-3.62%
Revenue growth 3Y4.55%
Revenue growth 5Y2.41%
Sales Q2Q%-3.36%
3.2 Future
BBH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.63% yearly.
The Revenue is expected to grow by 2.47% on average over the next years.
EPS Next Y21.13%
EPS Next 2Y18.35%
EPS Next 3Y15.63%
EPS Next 5YN/A
Revenue Next Year-2%
Revenue Next 2Y0.2%
Revenue Next 3Y1.31%
Revenue Next 5Y2.47%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
BBH is valuated quite expensively with a Price/Earnings ratio of 70.90.
Compared to the rest of the industry, the Price/Earnings ratio of BBH indicates a slightly more expensive valuation: BBH is more expensive than 76.83% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of BBH to the average of the S&P500 Index (26.03), we can say BBH is valued expensively.
Based on the Price/Forward Earnings ratio of 42.29, the valuation of BBH can be described as expensive.
Based on the Price/Forward Earnings ratio, BBH is valued a bit more expensive than the industry average as 79.27% of the companies are valued more cheaply.
The average S&P500 Price/Forward Earnings ratio is at 22.27. BBH is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 70.9 | ||
| Fwd PE | 42.29 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BBH is valued a bit more expensive than 76.83% of the companies in the same industry.
BBH's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. BBH is more expensive than 73.17% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 88.32 | ||
| EV/EBITDA | 23.57 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BBH does not grow enough to justify the current Price/Earnings ratio.
BBH's earnings are expected to grow with 15.63% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.36
PEG (5Y)43.16
EPS Next 2Y18.35%
EPS Next 3Y15.63%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.91%, BBH is a good candidate for dividend investing.
BBH's Dividend Yield is rather good when compared to the industry average which is at 4.32. BBH pays more dividend than 97.56% of the companies in the same industry.
BBH's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.91% |
5.2 History
The dividend of BBH is nicely growing with an annual growth rate of 7.84%!
BBH has paid a dividend for at least 10 years, which is a reliable track record.
BBH has decreased its dividend recently.
Dividend Growth(5Y)7.84%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
62.40% of the earnings are spent on dividend by BBH. This is not a sustainable payout ratio.
BBH's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP62.4%
EPS Next 2Y18.35%
EPS Next 3Y15.63%
NASDAQ:BBH (11/4/2025, 8:01:13 PM)
178.67
-1.36 (-0.76%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)
Earnings (Next)
Inst Owners46.28%
Inst Owner Change-3.36%
Ins Owners0%
Ins Owner ChangeN/A
Market Cap126.10B
Revenue(TTM)26.74B
Net Income(TTM)1.56B
Analysts80
Price Target203.39 (13.84%)
Short Float %0%
Short Ratio1.43
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.91% |
Yearly Dividend1.56
Dividend Growth(5Y)7.84%
DP62.4%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.19%
PT rev (3m)11.62%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-10.51%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.61%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 70.9 | ||
| Fwd PE | 42.29 | ||
| P/S | 4.1 | ||
| P/FCF | 88.32 | ||
| P/OCF | 32.37 | ||
| P/B | 6.18 | ||
| P/tB | 8.39 | ||
| EV/EBITDA | 23.57 |
EPS(TTM)2.52
EY1.41%
EPS(NY)4.23
Fwd EY2.36%
FCF(TTM)2.02
FCFY1.13%
OCF(TTM)5.52
OCFY3.09%
SpS43.63
BVpS28.91
TBVpS21.28
PEG (NY)3.36
PEG (5Y)43.16
Graham Number40.49
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.39% | ||
| ROE | 8.81% | ||
| ROCE | 10.41% | ||
| ROIC | 8.17% | ||
| ROICexc | 9.37% | ||
| ROICexgc | 11.66% | ||
| OM | 10.65% | ||
| PM (TTM) | 5.84% | ||
| GM | 27.6% | ||
| FCFM | 4.64% |
ROA(3y)5.45%
ROA(5y)4.73%
ROE(3y)10.95%
ROE(5y)10.02%
ROIC(3y)9.25%
ROIC(5y)8.5%
ROICexc(3y)10.45%
ROICexc(5y)9.86%
ROICexgc(3y)12.91%
ROICexgc(5y)12.2%
ROCE(3y)11.87%
ROCE(5y)10.97%
ROICexgc growth 3Y-1.17%
ROICexgc growth 5Y0.57%
ROICexc growth 3Y-1.78%
ROICexc growth 5Y0.45%
OM growth 3Y-2.46%
OM growth 5Y-1.24%
PM growth 3Y-3.58%
PM growth 5Y-0.79%
GM growth 3Y-0.99%
GM growth 5Y-0.59%
F-Score5
Asset Turnover0.75
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.32 | ||
| Debt/FCF | 6.05 | ||
| Debt/EBITDA | 1.17 | ||
| Cap/Depr | 107.96% | ||
| Cap/Sales | 8.01% | ||
| Interest Coverage | 9.96 | ||
| Cash Conversion | 70% | ||
| Profit Quality | 79.44% | ||
| Current Ratio | 1.8 | ||
| Quick Ratio | 1.12 | ||
| Altman-Z | 5.59 |
F-Score5
WACC7.88%
ROIC/WACC1.04
Cap/Depr(3y)113.8%
Cap/Depr(5y)101.88%
Cap/Sales(3y)7.8%
Cap/Sales(5y)7.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.28%
EPS 3Y0.78%
EPS 5Y1.64%
EPS Q2Q%-26.88%
EPS Next Y21.13%
EPS Next 2Y18.35%
EPS Next 3Y15.63%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.62%
Revenue growth 3Y4.55%
Revenue growth 5Y2.41%
Sales Q2Q%-3.36%
Revenue Next Year-2%
Revenue Next 2Y0.2%
Revenue Next 3Y1.31%
Revenue Next 5Y2.47%
EBIT growth 1Y-17.5%
EBIT growth 3Y1.98%
EBIT growth 5Y1.14%
EBIT Next Year59.12%
EBIT Next 3Y22.78%
EBIT Next 5Y17.41%
FCF growth 1Y-20.46%
FCF growth 3Y21.5%
FCF growth 5Y7.22%
OCF growth 1Y-10.1%
OCF growth 3Y14.27%
OCF growth 5Y5.48%
VANECK BIOTECH ETF / BBH FAQ
What does VANECK BIOTECH ETF do?
Compagnie Générale des Établissements Michelin SCA engages in the manufacture, distribution and sale of tires. The company is headquartered in Clermont-Ferrand, Auvergne-Rhone-Alpes and currently employs 127,500 full-time employees. The firm operates through three segments: Automotive, Road Transportation and Specialty Businesses. Automotive, which comprises the business lines Automotive business to customers (B2C) Global Brands, Automotive B2C Regional Brands, Automotive Original Equipment and Mobility Experiences. Road Transportation comprises the business lines Long Distance Transportation, Urban Transportation and Services & Solutions. Specialty Businesses comprises the business lines Mining, Off-Highway Transportation, Two-Wheel, Aircraft and High-Tech Materials. The company provides different kind of tires and related products and services through a dealership network. Its service offering includes truck driver assistance with Michelin Euro Assist, fleet tire advice, maintenance and management services and mobility assistance services, among others. Additionally, it provides branded lifestyle products and high-tech materials.
Can you provide the latest stock price for VANECK BIOTECH ETF?
The current stock price of BBH is 178.67 USD. The price decreased by -0.76% in the last trading session.
How is the ChartMill rating for VANECK BIOTECH ETF?
BBH has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Which stock exchange lists BBH stock?
BBH stock is listed on the Nasdaq exchange.